✦ LIBER ✦

Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myeloma

✍ Scribed by Moreau, P; Misbahi, R; Milpied, N; Morineau, N; Mahé, B; Vigier, M; Rapp, M J; Bataille, R; Harousseau, J L

Book ID: 110055172
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 116 KB
Volume: 16
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2402613

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term thalidomide therapy resulted i

Long-term thalidomide therapy resulted in lack of mdr1 gene expression in a patient with primary resistant multiple myeloma

✍ Hus, M; Dmoszyñska, A; Kocki, J; Hus, I; Jawniak, D; Adamczyk-Cioch, M; Grzasko, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

High-dose therapy and autologous periphe

High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients

✍ Massimo Martino; Giuseppe Console; Giuseppe Irrera; Giulia Praticò; Caterina Ste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 2 views

## Abstract The recent development of reduced intensity conditioning and allotransplantation (RICT) has opened a new way to assure engraftment of donor cells while reducing early transplant‐related mortality. We evaluated the combination of high‐dose therapy and autologous peripheral blood stem cel